![Favorite pages[Japanese page]](/files/000137013.png){kind=small}
](/files/000137010.png){kind=small}
- Home
- What's New
Here begins the text.
What's New
June 2, 2020English Translation of Review Report: Vizimpro
- June 1, 2020Revisions of PRECAUTIONS:Selexipag, etc. posted
- June 1, 2020PDG (Pharmacopoeial Discussion Group) Stage 2 Drafts (June, 2020) posted
- May 28, 2020PMDA Updates (May, 2020) posted
- May 22, 2020PMDA Risk Communication: Memantine hydrochloride, etc. posted
- May 21, 2020English translation of review summary: Espline SARS-CoV-2
- May 20, 2020ICMRA statement on COVID-19
- May 14, 2020JP17 Updated Errata, JP17-1 Errata, and JP17-2 Errata Posted
- May 13, 2020First Approval of Antigen Test for COVID-19
- May 12, 2020Global regulatory workshop on COVID-19 Real-World Evidence and Observational studies
- May 8, 2020Special Approval for Emergency on Remdesivir for COVID-19
- April 28, 2020MHLW Pharmaceuticals and Medical Devices Safety Information No.372
- April 21, 2020Four IVDs Approvals for COVID-19 and Response to the Increased Ventilator Demand
- April 21, 2020PMDA Medical Safety Informations Posted
- April 20, 2020Global regulatory workshop on COVID-19 therapeutic development
- April 10, 2020PMDA Takes Further Steps to Speed up Clinical Development of COVID-19 Products
- April 1, 2020Global regulatory workshop on COVID-19 vaccine development